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attributed the high incidence of skin morbidity to the low- energy neutron beam (7.5 MeV) with its poor physical char­
acteristics. Griffin et al/  found an increase in complications of 
about 30% with low-energy compared with high-energy neu­
trons. Complications are also related to the volume treated.
It is hoped that with high-energy machines and well-colli­
mated beams, the incidence of late effects will be reduced.
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Summary
The effect of transcutaneous electrical nerve stimula­
tion (TENS) plus conservative therapy (ibuprofen, bite 
plate, self-physiotherapy) on myofascial pain dysfunc­
tion (MPD) was determined. A single-blind trial was 
done in 10 patients with MPD with subthreshold 
TENS (frequency 35 Hz, pulse width 100 millisec­
onds, modulation 50%) compared with sham TENS at 
8 visits over 14 weeks. Pain was assessed on a visual 
analogue scale before and after TENS at each visit 
and the data were analysed with the analysis of vari­
ance (ANOVA) for repeated measures. A highly sig­
nificant effect was seen for time (F = 4.80, P = 
0.0003) but not for TENS. Subthreshold TENS did not 
increase the symptom relief produced by conservative 
treatment with the protocol used.
Chronic pain syndromes have been defined as persistent pain 
that lasts more than 6 months and are associated with 
behavioural and psychosocial factors.1 Chronic facial pain 
may be atypical and reported prevalence varies. Two recent 
studies, for example, have reported chronic pain syndrome 
prevalences of 86%2 and 12%,’ a large proportion of which 
was directly associated with the temporomandibular joint (TMJ) and adjacent tissues.
It is clear that chronic facial pain is an important problem. A common form of chronic facial pain is myofascial pain dys­
function (MPD), the broad concept of which was first 
described by Schwartz.4 In this syndrome complex diagnostic 
features vary slightly from clinician to clinician but common 
features are TMJ noise associated with mandibular move­
ment, myalgia and arthralgia resulting in limitation of move­
ment of the mandible, pain radiating from the pre-auricular 
area to local muscles, aching of the head and neck, and trig­
ger spot.: which are nodular areas of muscle which elicit pain 
if palpated. The pain is usually unilateral, and it is often 
worse on rising in the morning although it may intensify dur­ing the day.5 There are usually no clinical, biochemical or 
radiographic changes in the TMJ, since the primary site of the 
problem is not in the joint. Gelb6 stated that all patients with 
MPD have the following three factors: compromised neuro­
muscular, skeletal or dental tissues, emotional stress, and 
bruxing or clenching of the dentition (parafunction). In many 
individuals these factors are subclinical. In those individuals 
in whom one or more of the symptoms increase, MPD will 
become clinically evident.6
Treatment of the condition is usually conservative, consist­
ing of elimination of parafunctional habits like grinding or 
clenching of teeth, physiotherapy, anti-inflammatory drugs or 
a bite plate. Response to conservative treatment varies from 
patient to patient and is not always ideal, and additional treat­ment modalities are constantly being tested in order to 
improve results.
One proposed modality has been transcutaneous electrical 
nerve stimulation (TENS) in which electrical impulses of a
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defined frequency and wavelength are applied transcuta- 
neously via electrodes on the surface of the skin to produce 
local analgesia. The technique was used as early as 1858 for 
tooth extraction7 buc was abandoned until the ‘gate control 
theory’ of pain control was formulated by Melzack and Wall.3 
Since then several studies of TENS in MPD have been done. 
Some authors felt that the method had promise2*’'12 but others 
disagreed.13 The use of the TENS in the management of 
chronic facial pain has been documented. For example, 
Bremerich and colleagues’ study2 evaluated the efficacy of 
TENS in the treatment of various diverse forms of chronic 
facial pain. They concluded that TENS is a simple, safe and 
effective method of treating chronic facial pain. Most of the 
literature reviewed did not stipulate specific settings for the 
frequency, pulse width or modulation settings of TENS, an 
omission that makes comparative studies difficult.
The present study was done to evaluate the efficacy of 
TENS in the treatment of MPD through standardisation of 
11 independent variables: the type of TENS unit, the type 
and composition of the electrodes, the type and make of elec­
trode, the site of placement of the electrodes, the number of 
electrodes, the frequency of the electric impulse, the pulse 
width (wavelength) of the generated pulse, the intensity of the 
generated pulse, the modulation of the electric impulse, the 
duration of the TENS treatment, the number of treatment 
sessions and the time period between treatment sessions.
incisors with the splint was provided by spot grinding using Bausch BK01 blue articulation paper (Bausch KG, Koln, 
West Germany). The second TENS treatment followed. The 
articulation of the lower incisors to the splint was checked at 
each visit and adjusted if necessary. The third to the seventh 
visit comprised TENS treatment while the eighth and final 
visit consisted of TENS treatment, clinical evaluation and 
final explanation of the problem and discharge from the 
study. At each of the visits where TENS treatment was pro­
vided, pre- and post-TENS pain values were recorded using 
the VAS.
The clinical evaluation was repeated at this point using the 
TMJ clinic questionnaire to evaluate muscle tenderness. This 
was an indication of the patient’s response to treatment and 
determined whether the patient needed to continue treatment 
outside the scope of the study. If the latter was the case then 
the patient was referred back to the TMJ clinic for further 
management.
A Medimod TENS Unit # 44105 (Medical Devices 
Incorporated, St Paul, Minn., USA) (Fig. 1) was used. This 
is a dual channel machine which allows both left and right 
TMJs to be treated simultaneously and permits the frequen­
cy, wavelength and intensity to be varied. There is also a 
modulation facility which modulates the frequency and pulse 
width in a cyclical manner in order to minimise the possibility 
of tachyphylaxis to the generated pulse.
Material and methods
Prior to the commencement of the study the protocol was 
scrutinised by the University of the W itw atersrand’s 
Committee for Research on Human Subjects. Clearance was 
granted provided that no patient would be denied the benefit 
of accepted modes of conservative treatment. The trial design 
therefore consisted of a normal conservative management 
programme with TENS as an adjunct to this treatment.
The study was done at the TMJ clinic in the Division of 
Maxillofacial and Oral Surgery, University of the 
Witwatersrand. Patients were selected for the study after 
completion of a detailed TMJ questionnaire (available from 
the authors) and clinical examination. Only patients who 
presented with pure MPD, or those with MPD and an associ­
ated anterior dislocation of the meniscus with spontaneous reduction, were requested to join the study. Over an 18- 
month period 10 patients fulfilled the inclusion criteria and all 
consented to participate in the study knowing that a sham 
treatment was possible. The first patient was randomly allo­
cated to a group by drawing lots, thereafter patients were alternated into treatment groups. All patients received stan­
dard conservative management for MPD. In addition the 
control group was given sham TENS treatment while the test 
group received active TENS treatment.
At the first visit, after diagnosis and recruitment into the 
study, each patient received a brief explanation of the prob­
lem, and was counselled about possible parafunctional habits; 
a soft diet and a home physiotherapy programme were recom­
mended. In addition, ibuprofen 400 mg 3 times a day was prescribed for 1 week. Impressions of mandibular and maxil­
lary teeth were taken for the construction of a bite plate — an 
upper Hawley type which allowed occlusion of only the lower 
incisors with the plate while separating the premolar and 
molar teeth by approximately 2 - 3  mm. The first TENS 
treatment was given at this visit. The pain level was quantified 
on a pre- and post-TENS treatment visual analogue scale 
(VAS) from 0 (no pain) to 10 (unbearable pain). The VAS 
system was chosen because Shipton14 has termed it the best 
‘paper and pencil instrument’ for clinically assessing pain 
intensity. At the second visit the occlusal splint was fitted and 
an even contact flat plane occlusion of the patient’s lower
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Fig. 1. The TENS unit.
Reasoning for the selection of definitive frequency, pulse 
width and modulation values was twofold, the first being the 
success rates reported in previous studies and the second a 
desire for an easily reproducible method for further studies. 
Shipton14 describes a ‘low frequency high intensity stimulation 
pattern’ to be effective in the treatment of chronic pain. 
Linzer and Long reported a 74% success rate in pain relief 
with the use of frequencies of 14 - 60 Hz.15 Tulgar et al,16 reported that TENS frequencies of 20 - 80 Hz produced the 
greatest analgesic effect and used pulse widths ranging from 
50 to 200 microseconds in their study. Also reported in 
Tulgar’s study is that frequency-modulated stimulation seemed to be more effective than conventional constant-mode 
stimulation.
The frequency setting used in this study was one of a rela­
tively low frequency of 35 Hz, with reported success rates 
obtained using frequencies between 14 and 80 Hz. A pulse 
width of 110 microseconds was chosen also within the ranges 
used in prior studies. As frequency-modulated stimulation 
has been reported to be desirable, a modulation setting of 
50% was selected for the study.
Placement of electrodes involved the identification of trig­
ger point areas in the masseter and temporalis muscles by 
eliciting tenderness to palpation. Rubber electrodes 10 mm in 
diameter (Medical Devices Incorporated, St Paul, Minn., 
USA) were then placed with an adhesive electrode gel bilater­
ally on the masseter and temporalis trigger point areas (Fig. 
2). The TENS unit was switched on and the intensity was 
increased until the patient was aware of a sensation. The
IFig. 2. Placement of electrodes.
intensity was then decreased to subthreshold levels after 
which the patient was treated for 30 minutes. A threshold 
level was determined at each treatment session in order to 
adjust the intensity to the subthreshold level at that particular 
appointment.The TENS units for the control patients had electrode 
leads severed internally to ensure that the control TENS unit 
remained operative — with the red indicator light flashing, 
but the impulse generated did not reach the patient. No 
threshold was set with these patients, and they were unaware 
of the use of threshold sensation to set subthreshold treat­ment levels in the treatment patient group.
The data were then entered into the IBM 3083J24 main­
frame computer at the University of the Witwatersrand and 
analysed using SAS17 with an analysis of variance (ANOVA) 
for repeated measures test. The critical level for statistical sig­nificance was set at P < 0.05.
Results
Details of the patients are given in Table I. The gender ratio 
was 6 women to 4 men; die youngest patient was aged 21 
years and the oldest 58. In the control group the mean age 
was 40.2 years (SD 14.6) and in the treatment group the 
mean age was 36.8 (SD 15.6). The duration of symptoms 
varied between 5 and 60 months. The mean duration was 
longer in the control group (mean 26.2 months, SD 22.1) 
dian in the treatment group (mean 16.8 months, SD 10.7) 
because of the very long history of patient 3.The overall results of the study are summarised in Table II 
as mean pain scores. When the grouped values are examined 
greater fluctuation in pain scores can be seen in the control 
group. The TENS group shows a clear reduction in pain 
score over the 8 visits.
The repeated ANOVA results showed a highly statistically 
significant result for time (.F = 4.80, P = 0.0003), but treat­
ment and time interaction was not statistically significant (F = 
0.58, P=0.77), which indicates that TENS had no significant 
effect in the trial.
TABLE I. DETAILS OF PATIENTS
Group Patient Gender
Age
(yrs)
Duration of 
symptoms 
(mo.)
Control 1 F 52 18
2 M 50 12
3 F 28 SO
4 M 50 5
5 F 21 36
Treatment 6 M 27 12
7 F 58 12
8 F 24 12
9 F 26 12
10 M 49 36
Discussion
All the participants in the trial were enthusiastic, ready to try 
any additional treatment to alleviate their distress, and able to 
use the VAS to describe their pain. In this trial the patient was 
blind to the treatment but bias was minimised because each 
patient, and not the therapist, measured the pain score. Examination of the individual results of each patient (Table
TABLE II. MEAN (SD) PAIN SCORES BY GROUP, VISIT AND TIMING
Control group Treatment groups
Visit Pre-TENS Post-TENS Difference Pre-TENS Post-TENS Difference
1 55.6 (33.4) 41.6 (28.7) 14.0 (13.9) 60.8 (35.8) 44.8 (35.7) 16.0 (10.3)
2 44.8 (26.7) 35.8 (31.6) 9.0 (7.4) 48.6 (34.8) 41.6 (35.2) 7.0 (7.4)
3 22.0 (19.3) 19.0 (18.3) 3.0 (2.5) 37.4 (27.6) 32.0 (25.4) 5.4 (6.6)
4 20.4 (16.0) 20.8 (16.9) -0.4 (1.7) 21.4 (17.2) 17.8 (12.7) 3.6 (6.9)
5 17.0 (7.6) 13.6 (7.9) 3.4 (6.4) 21.2 (13.7) 17.2 (11.1) 4.0 (9.1)
6 20.6 (11.5) 16.8 (14.5) 3.8 (4.8) 19.8 (17.2) 20.0 (18.3) -0.2 (1.6)
7 22,4 (20.6) 17.6 (12.0) 4.8 (9.1) 22.2 (21.9) 21.2 (23.1) 1.0 (2.0)
8 17.8 (12.4) 14.8 (11.5) 3.0 (3.2) 15.4 (13.0) 16.4 (15.8) 1.0 (3.5)
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II) reveals that most patients, whether they wrere control or 
active treatment patients, responded well to the treatment 
that they received over the 14 weeks of the trial. This is 
shown by a reduction in pain compared with that at the initial 
presentation. Comparison of pre-and post-treatment pain val­
ues within the trial groups shows little difference between the 
response of the control and the treatment groups, an effect 
confirmed by the lack of statistical significance for TENS.
Possible reasons for the favourable response to the routine 
conservative programme could be attributed to the following 
factors. A major consideration is that of time being the pre­
dominant correcting factor. Would the patients have experi­
enced a significant improvement with increasing time no 
matter what therapy they were given? This theory is unlikely 
because most of the patients had been symptomatic for long 
periods before the treatment. Had time been the only factor 
to consider, they would have undergone spontaneous 
improvement long before presenting to the clinic for treat­
ment.
A second possibility is that the conservative regimen over 
the time of the study provided the patient with a satisfactory 
treatment combination. If this is true then TENS had little 
influence on the pain values that were recorded by the 
patients. It can also be concluded that the conservative pro­
gramme is a most effective mode of therapy for MPD. This is 
supported by the results of the statistical analysis of this study.
TENS may have played a passive role in the improvement 
of the patients’ pain. This would mean that the effect of 
TENS in this study was limited to a placebo effect and that 
the only benefit of this treatment modality was to address the 
psychological aspect of the MPD, i.e. that patients were being 
recognised as needing care and that they were receiving treat­
ment.
While the sample size was large enough to detect a signifi­
cant effect of time, it may have been too small to detect subtle 
improvement due to TENS. A larger sample size possibly 
would have shown a significant effect, but this is difficult to 
obtain if pure MPD is to be treated. Inclusion of patients with 
mixed conditions will add confounding variables. Another 
important factor is that the TENS therapy may not have been 
applied to the patient long enough per treatment session, and 
consultations may not have been frequent enough. Tire TMJ 
clinic operates once a week. This limiting factor resulted in 
visits being confined to the times made available at the clinic.
Ship ton'* advocates the use of supra-threshold levels, i.e. 
the intensity setting to be used is set at the highest intensity 
that the patient can comfortably tolerate. Literature studied 
prior to the initiation of the clinical trial recommended a 
TENS intensity that was increased to a level where the patient just became aware of a sensation and was then 
reduced to a subthreshold level.18,19 This method was chosen for the present investigation. Since completion of the study, 
the trend seems to have changed to favour the use of supra- 
threshold levels. Whether this method as described by 
Shipton would have produced better results is possibly a con­
sideration for a further study and needs to be tested before 
TENS is eliminated as a treatment for MPD.
A large proportion of patients with clinically oven MPD 
present with signs and symptoms of contributory emotional 
stress. This significant emotional stress may have reduced the 
efficacy of TENS since Meyler et al.20 have reported that 
TENS is less effective in patients with prominent psychologi­
cal and social distress.
Ideally a study to evaluate TENS in MPD without any 
other masking factors is needed. The problem is that it is ethi­
cally unjustifiable to withhold successful treatment from a 
patient.A direct comparison between the present study and other 
studies is difficult. Most other studies did not standardise 
their TENS settings as well as other variables so that subjec­
V*__" JL JL  1 ARTICLES
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tive opinions rather than objective measurements have been 
given. This makes comparison inaccurate and inappropriate.
Conclusion
Results of this study showed no statistically significant effect 
of TENS, delivered at a subthreshold level, on a weekly 30- 
minute treatment session, as an adjunct to conservative treat­
ment of MPD.
Opsomming
Die effek van transkutane elektriese senuwee-stimu- 
lasie (TESS) plus konserwatiewe behandeling 
(ibuprofen, bytplaat, self-fisioterapie) op miofasiale 
pyndisfunksie (MPD) is bepaal. 'n Enkele blinde proef 
is gedoen in 10 pasiente met MPD met behulp van 
subdrempelwaarde TESS (frekwensie 35 Hz, pols- 
wydte 100 millisekondes, modulasie 50%) in vergelyk- 
ing met vals TESS tydens 8 besoeke oor 14 weke. 
Tydens elke besoek is pyn voor en na TESS op ’n 
visuele analoogskaal gemeet en die data is met die 
variansie-analise vir herhaalde metings geanaliseer. 
‘n Hoogs betekenisvolle effek vir tyd is gesien (F = 
4.80, P = 0.0003), maar nie vir TESS nie. Subdrempel 
TESS het nie die simptoomverligting vermeerder wat 
met konserwatiewe behandeling met die gebruikte 
protoko! verkry is nie.
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